New Key Statistics Module, Z-Score and F-Score
NAS:BPMC Key Ratios
| Market Cap $ M | 5,977.15 |
| Enterprise Value $ M | 5,574.08 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 19.05 |
| Price/Sales | 13.60 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 434.00 |
| EPS (TTM) $ | -2.11 |
| Beneish M-Score | -1.94 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -62.42 |
| EV-to-EBITDA | -73.83 |
| PEG | -- |
| Shares Outstanding M | 63.53 |
| Net Margin (%) | -29.48 |
| Operating Margin % | -63.53 |
| Pre-tax Margin (%) | -29.34 |
| Quick Ratio | 3.27 |
| Current Ratio | 3.32 |
| ROA % (ttm) | -11.44 |
| ROE % (ttm) | -50.13 |
| ROIC % (ttm) | -62.46 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.91 |
BPMC Number of Guru Trades
BPMC Volume of Guru Trades
Gurus Latest Trades with NAS:BPMC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BPMC is held by these investors
Total 3
Blueprint Medicines Corp Insider Transactions
No Available Data
News about NAS:BPMC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers